These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32470213)

  • 21. COVID-19 and thrombosis: Beyond a casual association.
    López Castro J
    Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683
    [No Abstract]   [Full Text] [Related]  

  • 22. Dynamic relationship between D-dimer and COVID-19 severity.
    Li Y; Zhao K; Wei H; Chen W; Wang W; Jia L; Liu Q; Zhang J; Shan T; Peng Z; Liu Y; Yan X
    Br J Haematol; 2020 Jul; 190(1):e24-e27. PubMed ID: 32420615
    [No Abstract]   [Full Text] [Related]  

  • 23. D-Dimer serum levels as a biomarker associated for the lethality in patients with coronavirus disease 2019: a meta-analysis.
    Lima WG; Barra A; Brito JCM; Nizer WSC
    Blood Coagul Fibrinolysis; 2020 Jul; 31(5):335-338. PubMed ID: 32618589
    [No Abstract]   [Full Text] [Related]  

  • 24. Focus on coronavirus disease 2019 associated coagulopathy.
    Yang XH; Li RR; Sun RH; Liu J; Chen DC
    Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
    [No Abstract]   [Full Text] [Related]  

  • 25. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D-Dimer.
    Demirbaş A; Elmas ÖF; Türsen Ü; Atasoy M; Lotti T
    Dermatol Ther; 2020 Jul; 33(4):e13768. PubMed ID: 32500589
    [No Abstract]   [Full Text] [Related]  

  • 26. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.
    Roncon L; Zuin M; Zonzin P
    Thromb Res; 2020 Jun; 190():102. PubMed ID: 32335420
    [No Abstract]   [Full Text] [Related]  

  • 27. A dermatologic manifestation of COVID-19: Transient livedo reticularis.
    Manalo IF; Smith MK; Cheeley J; Jacobs R
    J Am Acad Dermatol; 2020 Aug; 83(2):700. PubMed ID: 32283229
    [No Abstract]   [Full Text] [Related]  

  • 28. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemostasis profile in COVID-19 infection.
    Duarte FB; Machado RPG; Lemes RPG; Duarte IA; Duarte BA; Machado CMG; Duarte JVA; Rocha SGMD; Moura ATG; Holanda RARR
    Rev Assoc Med Bras (1992); 2020 May; 66(5):571-572. PubMed ID: 32638971
    [No Abstract]   [Full Text] [Related]  

  • 30. The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.
    Thachil J; Longstaff C; Favaloro EJ; Lippi G; Urano T; Kim PY;
    J Thromb Haemost; 2020 Sep; 18(9):2408-2411. PubMed ID: 32881272
    [No Abstract]   [Full Text] [Related]  

  • 31. ST-Segment Elevation in Patients with Covid-19 - A Case Series.
    Bangalore S; Sharma A; Slotwiner A; Yatskar L; Harari R; Shah B; Ibrahim H; Friedman GH; Thompson C; Alviar CL; Chadow HL; Fishman GI; Reynolds HR; Keller N; Hochman JS
    N Engl J Med; 2020 Jun; 382(25):2478-2480. PubMed ID: 32302081
    [No Abstract]   [Full Text] [Related]  

  • 32. Routine haematology parameters in COVID-19 patients and clinical outcome: A Belgian single-centre study.
    Demeester S; Demuyser T; Fauconnier C; Heestermans R; Orlando C; Depreter B; Jochmans K
    Int J Lab Hematol; 2020 Dec; 42(6):e252-e255. PubMed ID: 32915507
    [No Abstract]   [Full Text] [Related]  

  • 33. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
    Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
    Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 and SIC (!).
    Nevzorov I; Tulamo R; Albäck A; Lassila R
    J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
    [No Abstract]   [Full Text] [Related]  

  • 35. The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
    Thachil J
    J Thromb Haemost; 2020 Aug; 18(8):1849-1852. PubMed ID: 32588535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research progress of coagulation dysfunction in coronavirus disease 2019].
    Zhong S; Wu F; Peng N; Xie Q; Song J; Li W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1135-1138. PubMed ID: 33081906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

  • 38. Thromboinflammatory response in SARS-CoV-2 sepsis.
    Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD
    Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary embolism in patients with COVID-19 pneumonia.
    Bompard F; Monnier H; Saab I; Tordjman M; Abdoul H; Fournier L; Sanchez O; Lorut C; Chassagnon G; Revel MP
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32398297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor Outcome of Intestinal Ischemic Manifestations of COVID-19.
    Norsa L; Bonaffini PA; Indriolo A; Valle C; Sonzogni A; Sironi S
    Gastroenterology; 2020 Oct; 159(4):1595-1597.e1. PubMed ID: 32569772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.